We are a pioneering presence in the Remote Patient Monitoring (RPM) and MedTech sectors. We use our innovative medical device technology with a disruptive business model as an RPM provider to offer the only RPM program with remote wheeze detection for respiratory disorders as well as a broad number of serious chronic conditions.
A Lifelong Partner For Our Patients.
As a differentiated RPM provider, our mission is to improve health outcomes for patients with chronic diseases from cardiovascular, diabetes, obesity and, exclusively, wheeze detection for respiratory disease.
We are Respectful
We are Accountable
We are One Team
We are Innovative
Respiri Limited (ASX:RSH, OTCQB:RSHUF) is an Australian e-Health SaaS company supporting respiratory health management focusing primarily on supporting the US healthcare market.
Respiri is listed on the Australian Securities Exchange (ASX) and trades on the OTCQB under the ticker “RSHUF” for North American based investors